AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank29
3Y CAGR+19.7%
5Y CAGR-4.2%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+19.7%/yr
vs -19.1%/yr prior
5Y CAGR
-4.2%/yr
Recent acceleration
Acceleration
+38.9pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.17+12.5%
20240.15+11.3%
20230.13+37.1%
20220.10-38.7%
20210.16-23.2%
20200.21-22.1%
20190.26+16.5%
20180.23+9.2%
20170.21-34.6%
20160.32-